Repurposing the FDA-approved raloxifene to potentiate gemcitabine cytotoxicity in pancreatic cancer

被引：0
|
作者：
Trinh, Jessica [1 ]
Badejo, Adeleke [2 ]
Love, Quintin [2 ]
True, Heather [2 ]
Rao, Deepa [2 ]
Malhotra, Ashim [2 ]
机构：
[1] Pacific Univ, Forest Grove, OR USA
[2] Pacific Univ, Sch Pharm, Hillsboro, OR USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
1212
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Repurposing of FDA-approved drugs against cancer - focus on metastasis
    Ozsvari, Bela
    Lamb, Rebecca
    Lisanti, Michael P.
    AGING-US, 2016, 8 (04): : 567 - 568
  • [2] Repurposing of FDA-approved drugs as novel radiosensitisers in hypoxic prostate cancer
    Bibby, B.
    Thiruthaneeswaran, N.
    Yang, L.
    McArt, D.
    O'Reilly, P.
    Roberts, D.
    Choudhury, A.
    West, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S195 - S195
  • [3] Re-Purposing FDA-approved Raloxifene to Target Apoptotic Proteins in KRAS-mutant Pancreatic Cancer
    Badejo, Adeleke Modupe
    Szlavich, Ellyssa
    McCreary, Jordan
    True, Heather
    Serrato, Ana
    Love, Quintin
    Malhotra, Ashim
    FASEB JOURNAL, 2017, 31
  • [4] Repurposing FDA-approved drugs as potential PARP inhibitors
    Eznarriaga, Maria
    Rahman, Taufiq
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2516 - 2516
  • [5] Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer
    Moraca, Federica
    Arciuolo, Valentina
    Marzano, Simona
    Napolitano, Fabiana
    Castellano, Giuliano
    D'Aria, Federica
    Di Porzio, Anna
    Landolfi, Laura
    Catalanotti, Bruno
    Randazzo, Antonio
    Pagano, Bruno
    Malfitano, Anna Maria
    Amato, Jussara
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 285
  • [6] Repurposing of FDA-approved Therapeutics to Identify Novel Radiosensitisers in Hypoxic Prostate Cancer
    Thiruthaneeswaran, N.
    Bibby, B. A. S.
    Yang, L.
    McArt, D.
    Choudhury, A.
    West, C.
    CLINICAL ONCOLOGY, 2018, 30 (03) : 195 - 196
  • [7] Repurposing FDA-approved drugs for anti-aging therapies
    Snell, Terry W.
    Johnston, Rachel K.
    Srinivasan, Bharath
    Zhou, Hongyi
    Gao, Mu
    Skolnick, Jeffrey
    BIOGERONTOLOGY, 2016, 17 (5-6) : 907 - 920
  • [8] Scientists Repurposing FDA-Approved Drugs to Fight against Viruses
    YAN Fusheng
    BulletinoftheChineseAcademyofSciences, 2019, 33 (03) : 187 - 188
  • [9] Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
    Huang, Yue
    Hsu, Jessica C.
    Koo, Hyun
    Cormode, David P.
    THERANOSTICS, 2022, 12 (02): : 796 - 816
  • [10] Repurposing an FDA-Approved Drug to Inhibit Bacterial Protein Toxins
    Borho, J.
    Eckert, A.
    Koegel, M.
    Barth, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S32 - S32
12345